semaglutide going off market Novo Nordisk Braces as Generic Weight Loss Drugs Come to Upend Semaglutide Market Share, Size &

[DOI] [PMC free article] [PubMed] [Google Scholar] 98.Cerroni C., Steiner A., Seanez L., Kwon S., Lewis A.S

Understanding your genetic predispositions in peptide pathways can support a more informed conversation with your provider about whether a lower-cost option like compounded oral semaglutide ($289/mo) might be effective for you, or whether a higher-potency alternative like compounded tirzepatide ($289/mo) offers better clinical value given your individual profile

Holst: First, congratulations

___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation